What works for whom? Determining the efficacy and harm of treatments for pain
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
There has been a tension between the needs of regulators and industry to demonstrate that interventions are effective and safe, and the needs of professionals to understand how well interventions will work for their patients, and patients to understand what might work for them as individuals. The custom has been to focus on statistical outcomes based on average results, but in-depth analysis based on outcomes obtained by individual patients demonstrates that few are average. Rather, a minority of patients achieve very large reductions in pain (responders), while the majority achieve little (nonresponders). Those who benefit in terms of pain also benefit in other areas, with improved sleep, fatigue, mood, function, quality of life, and ability to work. This changes how benefit and risk are seen; nonresponders should stop treatments that don't work and not, therefore, be exposed to risks, while responders have very large benefits to offset against rare but potentially serious harm. This alternative view, patient-centred and practice-orientated, has major implications for clinical practice, how and why we do clinical trials and how they are designed, how health economic evaluations are done, for decisions made by regulatory and other bodies, and for the theory and practice of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471 · cited 1×
“The standard of at least 50% pain intensity reduction is not only patient centred, but also defined by professionals as indicating ‘‘substantial’’ improvement [18].”
BackgroundNuesch, E., Dieppe, P., Reichenbach, S., Williams, S., Iff, S., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.d1165 · Cited by 730 · cited 2×
“While there is still some uncertainty, the majority of studies have found an association between chronic pain and increased mortality, and this is particularly the case for patients with the most severe pain [69,76] or walking disability [56].”
BackgroundSmall study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559 · cited 1×
“In chronic pain, studies with fewer than 100 patients per treatment arm show consistently larger treatment effects than those with 100 patients or more [57].”
BackgroundThe impact of chronic pain in the community.
Smith, B. H., Elliott, A. M., Chambers, W. A., Smith, W. C., Hannaford, P. C., & Penny, K. (2001) · Family Practice · doi:10.1093/fampra/18.3.292 · Cited by 540
The specific disease burden of neuropathic pain: Results of a French nationwide survey
Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D. (2011) · Pain · doi:10.1016/j.pain.2011.09.014 · Cited by 427
“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370
Self-citationMoore, R. A., Moore, O. A., Derry, S., Peloso, P. M., Gammaitoni, A. R., & Wang, H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107805 · Cited by 279
Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study
Torrance, N., Elliott, A. M., Lee, A. J., & Smith, B. H. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.07.006 · Cited by 276 · cited 2×
“While there is still some uncertainty, the majority of studies have found an association between chronic pain and increased mortality, and this is particularly the case for patients with the most severe pain [69,76] or walking disability [56].”
BackgroundSingle dose oral analgesics for acute postoperative pain in adults
Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub2 · Cited by 198 · cited 1×
“A Cochrane overview provides evidence on over 40 drug and dose combinations with trustworthy results, as well as highlighting many others with no data or where results are unreliable [48].”
BackgroundThe Impact and Burden of Chronic Pain in the Workplace: A Qualitative Systematic Review
Patel, A. S., Farquharson, R., Carroll, D., Moore, A., Phillips, C. J., Taylor, R. S., & Barden, J. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00547.x · Cited by 161 · cited 1×
“An extensive systematic review has examined the consequences of chronic pain for the workplace [59] and found a substantial negative impact on work-related outcomes like employment status, sickness absence, and presenteeism (being at work but not functioning properly).”
BackgroundSelf-citation
Cited by
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
“It is questionable how important direct comparisons may be; they compare average e icacy rates between di erent active therapies, but individual people may respond to one drug, but not another (Moore 2013b).”
BackgroundMethodInfluentialNon-invasive brain stimulation techniques for chronic pain
O'Connell, N. E., Wand, B. M., Marston, L., Spencer, S., & DeSouza, L. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008208.pub3 · Cited by 488
Pregabalin for neuropathic pain in adults
Derry, S., Bell, R. F., Straube, S., Wiffen, P. J., Aldington, D., & Moore, R. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub3 · Cited by 364
Non-invasive brain stimulation techniques for chronic pain
O'Connell, N. E., Marston, L., Spencer, S., DeSouza, L. H., & Wand, B. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008208.pub5 · Cited by 273
Lumley, M. A., Schubiner, H., Lockhart, N. A., Kidwell, K. M., Harte, S. E., Clauw, D. J., & Williams, D. A. (2017) · Pain · doi:10.1097/j.pain.0000000000001036 · Cited by 242
Metadata
- Authors
- Andrew Moore, R.
- Venue
- Pain
- Published
- 2013-12
- Volume
- 154
- Issue
- Supplement 1
- Pages
- S77-S86
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2086845154
- Cited by
- 49
- References
- 12
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What works for whom? Determining the efficacy and harm of treatments for pain. https://app.cochat.ai/papers/10.1016/j.pain.2013.03.024
- The paper
- Andrew Moore, R. (2013). What works for whom? Determining the efficacy and harm of treatments for pain. Pain. https://doi.org/10.1016/j.pain.2013.03.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.